Damage to gut bacteria linked with chemo-induced weight gain in breast cancer patients

(Press-News.org) EDMONTON — Researchers have found a link between chemotherapy-induced changes to gut bacteria and the unhealthy weight gain seen in breast cancer patients, pointing the way to potentially help survivors avoid obesity-related illness later in their lives. 

In newly published research, a team at the University of Alberta found that the patients treated with chemotherapy lost muscle mass and gained abdominal fat, which has been linked to heart disease, diabetes and even cancer recurrence. The chemo patients also exhibited signs of inflammation and significant changes to the number and variety of bacteria in their guts.

“Changes in the bacterial populations within the gut directly correlate with unhealthy weight gain and increased body fat composition in breast cancer patients who were treated with chemotherapy,” says John Walker, professor in the Faculty of Medicine & Dentistry and head of medical oncology for northern Alberta at the Cross Cancer Institute, who co-led the study with Gane Ka-Shu Wong, professor in the departments of medicine and biological sciences.

 

Obesity has been linked with several kinds of cancer, including breast cancer, and oncologists have long observed that cancer treatment seems to make it worse. Many people lose weight after a cancer diagnosis, but that trend is reversed in breast cancer patients who undergo chemotherapy. Studies have shown that while 50 per cent of breast cancer patients are overweight or obese before their diagnosis, that rate goes up to 67 per cent after treatment. 

Changes to diet or exercise patterns during treatment are simply not significant enough to explain that difference, since they affect all patients who are treated for cancer, Walker notes. 

“People tend to be a little less active during and after chemotherapy but they also tend to significantly reduce their caloric intake,” he says. ”There's something unique about this modulation of the gut microbiome for breast cancer patients who receive chemotherapy.”

Walker notes it is not surprising that chemotherapy drugs have bacteria-killing effects, since some are derived from antibiotics and all are metabolized through the liver and then the gut.

“Breast cancer is an unparalleled success story in medicine. We see cure rates over 90 per cent today, so survivorship is now equally important. We want to ensure that in survival, our patients aren’t then dealing with the metabolic consequences of weight gain during treatment.” 

To speak with Dr. Walker or Dr. Wong about the study, please contact:

Michael Brown, U of A media strategist
michael.brown@ualberta.ca
780-977-1411

 

END